ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $57,000 | +5.6% | 23,449 | 0.0% | 0.00% | – |
| Q2 2020 | $54,000 | -15.6% | 23,449 | 0.0% | 0.00% | – |
| Q1 2020 | $64,000 | +128.6% | 23,449 | 0.0% | 0.00% | – |
| Q4 2019 | $28,000 | +12.0% | 23,449 | 0.0% | 0.00% | – |
| Q3 2019 | $25,000 | -30.6% | 23,449 | 0.0% | 0.00% | – |
| Q2 2019 | $36,000 | -61.3% | 23,449 | 0.0% | 0.00% | – |
| Q1 2019 | $93,000 | +50.0% | 23,449 | 0.0% | 0.00% | – |
| Q4 2018 | $62,000 | -64.0% | 23,449 | 0.0% | 0.00% | – |
| Q3 2018 | $172,000 | +4.9% | 23,449 | 0.0% | 0.00% | – |
| Q2 2018 | $164,000 | -24.8% | 23,449 | 0.0% | 0.00% | – |
| Q1 2018 | $218,000 | +23.9% | 23,449 | -0.2% | 0.00% | – |
| Q4 2017 | $176,000 | -29.6% | 23,496 | +0.2% | 0.00% | -100.0% |
| Q3 2017 | $250,000 | -7.4% | 23,449 | -0.8% | 0.00% | 0.0% |
| Q2 2017 | $270,000 | +7.1% | 23,649 | +0.9% | 0.00% | 0.0% |
| Q1 2017 | $252,000 | -5.6% | 23,449 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $267,000 | -8.9% | 23,449 | -0.4% | 0.00% | 0.0% |
| Q3 2016 | $293,000 | – | 23,549 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 5,118,560 | $12,438,000 | 0.72% |
| Rubric Capital Management LP | 1,629,321 | $3,959,000 | 0.37% |
| Burrage Capital Management LLC | 135,898 | $330,000 | 0.26% |
| Artal Group S.A. | 902,500 | $2,193,000 | 0.05% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,141,278 | $2,773,000 | 0.05% |
| Point72 Asset Management, L.P. | 2,050,000 | $4,982,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 567,181 | $1,378,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 34,241 | $83,000 | 0.01% |
| Renaissance Technologies | 4,384,010 | $10,653,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 802,749 | $1,951,000 | 0.01% |